Companies: 10,795·Total market cap: $144.5T
C4 Therapeutics, Inc.

C4 Therapeutics, Inc.

CCCCNASDAQHealthcare● Active
$3.67
$-0.18(-4.68%)
Market Cap$303975780
P/E Ratio
52W High$4.598
52W Low$1.36

C4 Therapeutics, Inc. (CCCC) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · CCCC · as of Feb 26, 2026

Latest filing snapshot

104
-6-5.45%vs prior year

C4 Therapeutics, Inc. (CCCC) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing

SEC 10-K·Period end: 2025-12-31·Full-time · Global
Total Employees
104
Change (1Y)
-6
Growth % (1Y)
-5.45%
Revenue / Employee
$345.6K
Net Income / Employee
$-1.01M
Market Cap
$301M

CCCC Employee Count

2020 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing DateEmployeesChange (1Y)Growth (1Y)SEC filing link
2026-02-26104-6-5.45%
2025-02-27110-35-24.14%
2024-02-22145-1-0.68%
2023-02-23146+25+20.66%
2022-02-24121+22+22.22%
2021-03-1199

Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology
#SymbolCompanyEmployees
#1
Codexis, Inc.
CDXS
Codexis, Inc.
188
#2
Molecular Partners AG
MOLN
Molecular Partners AG
158
#3
C4 Therapeutics, Inc.
CCCC
C4 Therapeutics, Inc.YOU
104
#4
Armata Pharmaceuticals, Inc.
ARMP
Armata Pharmaceuticals, Inc.
60
#5
Cybin Inc.
CYBN
Cybin Inc.
50
#6
Insight Molecular Diagnostics Inc.
IMDX
Insight Molecular Diagnostics Inc.
46
#7
Milestone Pharmaceuticals Inc.
MIST
Milestone Pharmaceuticals Inc.
33
Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · CCCC peer comparison

About CCCC employees

CCCC Employees · Headcount

C4 Therapeutics, Inc. (CCCC) employee data is sourced from the annual SEC 10-K filing. As of 2025, C4 Therapeutics, Inc. had 104 full-time employees globally. Full-time employees only. Global consolidated headcount.

C4 Therapeutics, Inc. employs 104 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $345,644, reflecting the company's operational efficiency.

C4 Therapeutics, Inc.'s workforce decreased by 6 (5.45%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

C4 Therapeutics, Inc.'s revenue per employee of $345,644 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Frequently Asked Questions

CCCC Employees · 5 questions

As of the latest SEC 10-K filing (2025), C4 Therapeutics, Inc. had 104 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

C4 Therapeutics, Inc. employee counthow many employees does C4 Therapeutics, Inc. haveCCCC total employees 2025

Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-02-26